Abstract:Future advances in therapeutics demand the development of dynamic and intelligent living materials. The past static monofunctional materials shall be unable to meet the requirements of future medical development. Also, the demand for precision medicine has increased with the progressively developing human society. Therefore, engineered living materials (ELMs) are vitally important for biotherapeutic applications. These ELMs can be cells, microbes, biofilms, and spores, representing a new platform for treating intractable diseases. Synthetic biology plays a crucial role in the engineering of these living entities. Hence, in this review, the role of synthetic biology in designing and creating genetically engineered novel living materials, particularly bacteria, has been briefly summarized for diagnostic and targeted delivery. The main focus is to provide knowledge about the recent advances in engineered bacterial-based therapies, especially in the treatment of cancer, inflammatory bowel diseases, and infection. Microorganisms, particularly probiotics, have been engineered for synthetic living therapies. Furthermore, these programmable bacteria are designed to sense input signals and respond to disease-changing environments with multipronged therapeutic outputs. These ELMs will open a new path for the synthesis of regenerative medicines as they release therapeutics that provide in situ drug delivery with lower systemic effects. In last, the challenges being faced in this field and the future directions requiring breakthroughs have been discussed. Conclusively, the intent is to present the recent advances in research and biomedical applications of engineered bacteria-based therapies during the last 5 years, as a novel treatment for uncontrollable diseases.

Bacterial synthetic biology: tools for novel drug discovery

Synthetic Biology for Therapeutic Applications

Synthetic biology advances for pharmaceutical production

Applications of synthetic biology in medical and pharmaceutical fields

Advance on Engineering of Bacteriophages by Synthetic Biology

Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs

Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Strategies to access biosynthetic novelty in bacterial genomes for drug discovery

Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria

Drug Discovery And Development Via Synthetic Biology

Recent advances in bacterial therapeutics based on sense and response

Microbial synthesis of drugs and fuels via synthetic biology

Recent Advances in the Synthetic Biology of Natural Drugs

Engineering living therapeutics with synthetic biology

Surface-modified bacteria: synthesis, functionalization and biomedical applications

Using bacterial genomes and essential genes for the development of new antibiotics

A Perspective on Synthetic Biology in Drug Discovery and Development—Current Impact and Future Opportunities

Development of bacteria as diagnostics and therapeutics by genetic engineering

Genetic Engineering of Bacteriophages Against Infectious Diseases

Engineered Bacteria-Based Living Materials for Biotherapeutic Applications